Table 3.
Body fat distribution measures and breast cancer risk
| |
Pre-menopausal |
Post-menopausal |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cases/Controls | OR1 | 95% CI | OR2 | 95% CI | Cases/Controls | OR1 | 95% CI | OR2 | 95% CI | |
|
Waist to hip ratio |
|
|
|
|
|
|
|
|
|
|
| ≤0.82 |
123/144 |
Ref |
|
Ref |
|
65/93 |
Ref |
|
Ref |
|
| 0.83–0.87 |
128/120 |
1.14 |
0.79–1.65 |
1.20 |
0.82–1.74 |
146/117 |
1.58 |
1.03–2.40 |
1.59 |
1.04–2.42 |
| 0.88–0.92 |
105/121 |
0.98 |
0.66–1.44 |
1.07 |
0.72–1.60 |
120/116 |
1.22 |
0.79–1.88 |
1.24 |
0.80–1.92 |
| >0.92 |
104/93 |
1.19 |
0.80–1.79 |
1.38 |
0.89–2.12 |
169/144 |
1.43 |
0.95–2.18 |
1.48 |
0.97–2.26 |
| p for trend |
|
|
0.55 |
|
0.22 |
|
|
0.33 |
|
0.27 |
|
Waist circumference (cm) |
|
|
|
|
|
|
|
|
|
|
| ≤87.88 |
137/143 |
Ref |
|
Ref |
|
87/94 |
Ref |
|
Ref |
|
| 87.89–97.75 |
124/119 |
1.02 |
0.70–1.46 |
1.26 |
0.85–1.88 |
119/118 |
1.07 |
0.71–1.61 |
1.13 |
0.73–1.76 |
| 97.76–110.25 |
107/116 |
0.93 |
0.64–1.37 |
1.47 |
0.88–2.44 |
154/121 |
1.35 |
0.90–2.02 |
1.51 |
0.92–2.48 |
| >110.25 |
92/100 |
0.98 |
0.65–1.48 |
2.25 |
1.07–4.74 |
140/137 |
1.00 |
0.67–1.50 |
1.23 |
0.64–2.34 |
| p for trend |
|
|
0.84 |
|
0.04 |
|
|
0.96 |
|
0.48 |
| Per 5 cm |
|
0.99 |
0.95–1.03 |
1.10 |
1.00–1.22 |
|
1.00 |
0.96–1.04 |
1.03 |
0.94–1.13 |
|
Hip circumference (cm) |
|
|
|
|
|
|
|
|
|
|
| ≤103.18 |
127/138 |
Ref |
|
Ref |
|
107/99 |
Ref |
|
Ref |
|
| 103.19–111.63 |
133/111 |
1.25 |
0.86–1.81 |
1.60 |
1.07–2.39 |
129/126 |
0.99 |
0.67–1.47 |
0.99 |
0.65–1.51 |
| 111.64–123.15 |
101/116 |
1.00 |
0.68–1.46 |
1.60 |
0.98–2.60 |
145/122 |
1.16 |
0.79–1.72 |
1.16 |
0.71–1.89 |
| >123.15 |
100/113 |
1.07 |
0.72–1.59 |
2.91 |
1.39–6.10 |
119/123 |
0.88 |
0.59–1.31 |
0.87 |
0.45–1.71 |
| p for trend |
|
|
0.99 |
|
0.01 |
|
|
0.54 |
|
0.69 |
| Per 5 cm | 0.98 | 0.93–1.03 | 1.12 | 0.99–1.27 | 0.98 | 0.94–1.03 | 0.97 | 0.87–1.08 | ||
OR1: Adjusted for age, ethnicity, country of origin (United States, Caribbean, other), education, family history of breast cancer, history of benign breast disease, age at menarche, age at menopause (for postmenopausal women), parity (continuous), breastfeeding (yes/no), age at first birth, HRT use (ever/never), OC use (ever/never). OR2: Further adjusted for BMI.